Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno (Q73567637)
Jump to navigation
Jump to search
scientific article published on 01 March 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor progno |
scientific article published on 01 March 2001 |
Statements
Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis (English)
D H Christiansen
M K Andersen
J Pedersen-Bjergaard